TrialCPT: pharmacometrics & systems pharmacology2020

Modeling Tumor Growth and Treatment Resistance Dynamics Characterizes Different Response to Gefitinib or Chemotherapy in Non-Small Cell Lung Cancer.

Mario Nagase et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.